Dimerization Through the Helix-Loop-Helix Motifenhances Phosphorylation of the Transcription Activation Domains of Myogenin

Total Page:16

File Type:pdf, Size:1020Kb

Dimerization Through the Helix-Loop-Helix Motifenhances Phosphorylation of the Transcription Activation Domains of Myogenin MOLECULAR AND CELLULAR BIOLOGY, Sept. 1994, p. 6232-6243 Vol. 14, No. 9 0270-7306/94/$04.00+0 Copyright © 1994, American Society for Microbiology Dimerization through the Helix-Loop-Helix Motif Enhances Phosphorylation of the Transcription Activation Domains of Myogenin JUMIN ZHOU AND ERIC N. OLSON* Department of Biochemistry and Molecular Biology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030 Received 6 December 1993/Returned for modification 4 February 1994/Accepted 6 June 1994 The muscle-specific basic helix-loop-helix (bHLH) protein myogenin activates muscle transcription by binding to target sequences in muscle-specific promoters and enhancers as a heterodimer with ubiquitous bHLH proteins, such as the E2A gene products E12 and E47. We show that dimerization with E2A products potentiates phosphorylation of myogenin at sites within its amino- and carboxyl-terminal transcription activation domains. Phosphorylation of myogenin at these sites was mediated by the bHLH region of E2A products and was dependent on dimerization but not on DNA binding. Mutations of the dimerization- dependent phosphorylation sites resulted in enhanced transcriptional activity of myogenin, suggesting that their phosphorylation diminishes myogenin's transcriptional activity. The ability ofE2A products to potentiate myogenin phosphorylation suggests that dimerization induces a conformational change in myogenin that unmasks otherwise cryptic phosphorylation sites or that E2A proteins recruit a kinase for which myogenin is a substrate. That phosphorylation of these dimerization-dependent sites diminished myogenin's transcrip- tional activity suggests that these sites are targets for a kinase that interferes with muscle-specific gene expression. A variety of transcription factors bind DNA and activate nin, myf5, and MRF4 (reviewed in references 15, 36, 37, and transcription as heterodimers. Interactions among heterolo- 49). These myogenic bHLH proteins bind DNA weakly by gous transcription factors provide opportunities for positive themselves but acquire high affinity for the E box consensus and negative control of gene transcription and dramatically sequence upon heterodimerization with several ubiquitous expand the regulatory potential of different classes of tran- bHLH proteins, referred to as E proteins. Among the E scription factors. In many cases, each component of a het- proteins that have been shown to serve as partners for myo- erodimer binds DNA weakly on its own but shows enhanced genic bHLH proteins are E12 and E47, encoded by the E2A DNA-binding activity when associated with the appropriate gene, and the HEB gene product (9, 21, 25, 34). Activation of partner. While it is conceivable that heterodimerization could muscle-specific transcription ensues when heterodimers of also alter the properties of the transcription factors them- myogenic bHLH proteins and E proteins bind to E boxes in the selves, there is as yet little evidence for this type of cooperat- control regions of muscle-specific genes. ivity among dimerization partners. Intracellular growth factor signals interfere with the ability The helix-loop-helix (HLH) family of transcription factors of myogenic bHLH proteins to activate muscle-specific tran- includes a wide range of regulatory proteins that control gene scription through several different mechanisms (reviewed in transcription in species ranging from Drosophila melanogaster reference 37). Recently, we showed that protein kinase C to humans (reviewed in reference 23). The HLH motif medi- (PKC) can block myogenesis through phosphorylation of a site ates dimerization and brings together the basic regions of HLH in the DNA-binding domain of myogenin that is specific to and proteins to form a composite DNA-binding domain that conserved in all myogenic bHLH proteins (28). Phosphoryla- recognizes the consensus sequence CANNTG (where N is any tion of site attenuates the of nucleotide), known as an E box (2, 33). Most HLH proteins this transcriptional activity preferentially form heterodimers with specific HLH protein myogenin by inhibiting its ability to bind DNA. Protein kinase partners (10, 34). The ability of individual basic HLH (bHLH) A (PKA) also phosphorylates the myogenin DNA-binding proteins to recognize distinct half-sites within the dyad sym- domain, but phosphorylation by PKA does not appear to metry of the E box consensus sequence therefore allows influence myogenin's ability to activate muscle transcription different combinations of HLH proteins to discriminate be- (26). In addition to sites for phosphorylation by PKC and PKA, tween different E boxes (2). HLH proteins lacking basic myogenin contains several other phosphorylation sites, the regions can inhibit the activities of bHLH proteins by forming locations of which remain to be determined (26, 28). MyoD, heterodimers that are incapable of binding DNA (1). myf5, and MRF4 are also highly phosphorylated, but the sites Skeletal muscle gene expression is controlled by a family of for phosphorylation in these proteins have likewise not yet muscle-specific bHLH proteins which includes MyoD, myoge- been mapped (17, 25, 32, 46, 52). Here we show that dimerization with E2A gene products results in an increase in the phosphorylation of myogenin at * Corresponding author. Mailing address: Department of Biochem- sites within its amino- and carboxyl-terminal transcription istry and Molecular Biology, Box 117, The University of Texas M. D. activation domains. Replacement of these sites with neutral Anderson Cancer Center, 1515 Holcombe Blvd., Houston, TX 77030. amino acids that prevent phosphorylation enhances the ability Phone: (713) 792-3648. Fax: (713) 791-9478. of myogenin to activate E box-dependent reporter genes and 6232 VOL. 14, 1994 DIMERIZATION-DEPENDENT PHOSPHORYLATION OF MYOGENIN 6233 potentiates the activity of myogenin's transcription activation and loaded onto a 10% polyacrylamide-SDS gel. Following domains when they are fused to the DNA-binding domain of electrophoresis, the gel was dried and processed for autora- the yeast protein GAL4. The ability of E2A products to diography. enhance phosphorylation of myogenin suggests that dimeriza- Phosphopeptide mapping and phosphoamino acid analysis. tion induces a conformational change in myogenin that ex- For phosphoamino acid analysis, 32P-labeled myogenin was poses otherwise cryptic phosphorylation sites or that E2A excised from SDS gel slices, which were then hydrated in water products recruit a kinase for which myogenin is a substrate. and rinsed in 50 mM NH4HCO3. The labeled protein was That phosphorylation of the dimerization-dependent sites di- ground into pieces and boiled for 3 min in 1 ml of 50 mM minishes myogenin's activity also suggests that the dimeriza- NH4HCO3 with 5 ,ul of and 10 p.l of tion-dependent kinase plays a negative role in regulating the ,B-mercaptoethanol 10% myogenic program. SDS. After a 5-h incubation at 37°C, the eluted proteins were precipitated in cold 15% trichloroacetic acid in the presence of 20 p.g of heat-treated RNase A. After overnight incubation on MATERIALS AND METHODS ice, the trichloroacetic acid precipitates were collected by Cell culture and transfections. Transfections were per- centrifugation for 10 min at 4°C and washed with 500 p.l of formed by calcium phosphate precipitation as described before ice-cold absolute ethanol. The pellet was then dried in air and (28). Briefly, COS-1 or 1OT1/2 cells were plated at 50% subjected to peptide mapping as described elsewhere (28) or confluency, and 1 day later, each plate of cells was refed with resuspended in 6 N HCl for phosphoamino acid analysis. Dulbecco's minimal essential medium (DMEM) containing Protein was then hydrolyzed for 2.5 h, and the partial acid 10% fetal bovine serum (2 ml for 60-mm dishes and 4 ml for hydrolysates were mixed with 3 p.g of phosphoserine, phospho- 100-mm dishes) and transfected within 4 h. Calcium phos- threonine, and phosphotyrosine (Sigma) and resolved by two- phate-DNA precipitates were prepared by adding 250 ,ul of 2x dimensional electrophoresis, with the first dimension at pH 1.9 HBS (0.818% NaCl, 0.594% HEPES [N-2-hydroxyethylpipera- and the second dimension at pH 3.5 (acetic acid-pyridine- zine-N'-2-ethanesulfonic acid], 0.02% Na2HPO4 [pH 7.12]) to water, 50:5:945). The thin-layer chromatography plate was first 250 p.l of 250 mM calcium chloride plus DNA (5 pLg per 60-mm visualized by autoradiography, and the phosphoamino acid plate). At 4 to 16 h after transfection, the medium was replaced standards were visualized after the plate was sprayed with with fresh DMEM containing 10% fetal bovine serum. For 0.25% ninhydrin in acetone and incubated for 10 min at chloramphenicol acetyltransferase (CAT) assays, transfected 650C. cells were refed with DMEM containing 2% horse serum 24 h Myogenin and E47 mutants. Site-directed mutagenesis was following transfection and allowed to differentiate for 2 days performed by PCR. All mutations were confirmed by DNA before being harvested. CAT activity was determined on aliquots of cell extract normalized to,-galactosidase activity as sequencing. described before (28). All assays were linear with respect to The following myogenin deletion mutants were made: protein concentration. DM1-33 was made by insertion of a SmaI fragment from the The reporter plasmid MCK-CAT contains the basal pro- myogenin cDNA (14), extending from codon 33 to the 3' end moter and muscle-specific enhancer from the mouse muscle of the transcript, into the SmaI site of the pECE-Flag vector creatine kinase (MCK) gene (45). Plasmid 4R-tkCAT (gener- (IBI), creating a Flag epitope-tagged protein. An NcoI-XbaI ously provided by A. Lassar) contains four tandem copies of fragment that encompassed the myogenin coding region was the high-affinity right-hand E box from the MCK enhancer isolated from this vector, the ends were filled in with de- linked to the thymidine kinase (tk) gene basal promoter (48). oxynucleotide triphosphates and Klenow polymerase, and the The GAL4 reporter plasmid pG5E1bCAT contains five copies fragment was subcloned into a filled EcoRI site of the vector of the GAL4 binding site upstream of the Elb promoter (29).
Recommended publications
  • SUPPLEMENTARY MATERIAL Bone Morphogenetic Protein 4 Promotes
    www.intjdevbiol.com doi: 10.1387/ijdb.160040mk SUPPLEMENTARY MATERIAL corresponding to: Bone morphogenetic protein 4 promotes craniofacial neural crest induction from human pluripotent stem cells SUMIYO MIMURA, MIKA SUGA, KAORI OKADA, MASAKI KINEHARA, HIROKI NIKAWA and MIHO K. FURUE* *Address correspondence to: Miho Kusuda Furue. Laboratory of Stem Cell Cultures, National Institutes of Biomedical Innovation, Health and Nutrition, 7-6-8, Saito-Asagi, Ibaraki, Osaka 567-0085, Japan. Tel: 81-72-641-9819. Fax: 81-72-641-9812. E-mail: [email protected] Full text for this paper is available at: http://dx.doi.org/10.1387/ijdb.160040mk TABLE S1 PRIMER LIST FOR QRT-PCR Gene forward reverse AP2α AATTTCTCAACCGACAACATT ATCTGTTTTGTAGCCAGGAGC CDX2 CTGGAGCTGGAGAAGGAGTTTC ATTTTAACCTGCCTCTCAGAGAGC DLX1 AGTTTGCAGTTGCAGGCTTT CCCTGCTTCATCAGCTTCTT FOXD3 CAGCGGTTCGGCGGGAGG TGAGTGAGAGGTTGTGGCGGATG GAPDH CAAAGTTGTCATGGATGACC CCATGGAGAAGGCTGGGG MSX1 GGATCAGACTTCGGAGAGTGAACT GCCTTCCCTTTAACCCTCACA NANOG TGAACCTCAGCTACAAACAG TGGTGGTAGGAAGAGTAAAG OCT4 GACAGGGGGAGGGGAGGAGCTAGG CTTCCCTCCAACCAGTTGCCCCAAA PAX3 TTGCAATGGCCTCTCAC AGGGGAGAGCGCGTAATC PAX6 GTCCATCTTTGCTTGGGAAA TAGCCAGGTTGCGAAGAACT p75 TCATCCCTGTCTATTGCTCCA TGTTCTGCTTGCAGCTGTTC SOX9 AATGGAGCAGCGAAATCAAC CAGAGAGATTTAGCACACTGATC SOX10 GACCAGTACCCGCACCTG CGCTTGTCACTTTCGTTCAG Suppl. Fig. S1. Comparison of the gene expression profiles of the ES cells and the cells induced by NC and NC-B condition. Scatter plots compares the normalized expression of every gene on the array (refer to Table S3). The central line
    [Show full text]
  • Role of the Nuclear Receptor Rev-Erb Alpha in Circadian Food Anticipation and Metabolism Julien Delezie
    Role of the nuclear receptor Rev-erb alpha in circadian food anticipation and metabolism Julien Delezie To cite this version: Julien Delezie. Role of the nuclear receptor Rev-erb alpha in circadian food anticipation and metabolism. Neurobiology. Université de Strasbourg, 2012. English. NNT : 2012STRAJ018. tel- 00801656 HAL Id: tel-00801656 https://tel.archives-ouvertes.fr/tel-00801656 Submitted on 10 Apr 2013 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. UNIVERSITÉ DE STRASBOURG ÉCOLE DOCTORALE DES SCIENCES DE LA VIE ET DE LA SANTE CNRS UPR 3212 · Institut des Neurosciences Cellulaires et Intégratives THÈSE présentée par : Julien DELEZIE soutenue le : 29 juin 2012 pour obtenir le grade de : Docteur de l’université de Strasbourg Discipline/ Spécialité : Neurosciences Rôle du récepteur nucléaire Rev-erbα dans les mécanismes d’anticipation des repas et le métabolisme THÈSE dirigée par : M CHALLET Etienne Directeur de recherche, université de Strasbourg RAPPORTEURS : M PFRIEGER Frank Directeur de recherche, université de Strasbourg M KALSBEEK Andries
    [Show full text]
  • Transcriptomic Characterisation of the Molecular Mechanisms Induced by Rgma During Skeletal Muscle Hyperplasia and Hypertrophy
    Transcriptomic Characterisation of the Molecular Mechanisms Induced by RGMa During Skeletal Muscle Hyperplasia and Hypertrophy Aline Gonçalves Lio Copola Universidade Federal de Minas Gerais Íria Gabriela Dias dos Santos Universidade Federal de Minas Gerais Luiz Lehmann Coutinho Universidade de São Paulo Luiz Eduardo Vieira Del Bem Universidade Federal de Minas Gerais Paulo Henrique de Almeida Campos Junior Federal University of São João del-Rei Júlia Meireles Nogueira Universidade Federal de Minas Gerais Alinne do Carmo Costa Universidade Federal de Minas Gerais Gerluza Aparecida Borges Silva Universidade Federal de Minas Gerais Erika Cristina Jorge ( [email protected] ) Universidade Federal de Minas Gerais Research Article Keywords: Axon Guidance, myogenesis, hypertrophy, hyperplasia, skeletal muscle differentiation, transcriptomic analysis Posted Date: June 29th, 2021 DOI: https://doi.org/10.21203/rs.3.rs-646954/v1 License: This work is licensed under a Creative Commons Attribution 4.0 International License. Read Full License Page 1/25 Abstract Background: The repulsive guidance molecule a (RGMa) is a GPI-anchor axon guidance molecule rst found to play important roles during neuronal development. RGMa expression patterns and signalling pathways via Neogenin and/or as BMP coreceptors indicated that this axon guidance molecule could also be working in other processes and diseases, including during myogenesis. Previous works have consistently shown that RGMa is expressed in skeletal muscle cells and that its overexpression induces both nuclei accretion and hypertrophy in muscle cell lineages. However, the cellular components and molecular mechanisms induced by RGMa during the differentiation of skeletal muscle cells are poorly understood. In this work, the global transcription expression prole of RGMa-treated C2C12 myoblasts during the differentiation stage, obtained by RNA- seq, were reported.
    [Show full text]
  • Temporal Change in Gene Expression in the Rat Dentate Gyrus Following Passive Avoidance Learning
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by MURAL - Maynooth University Research Archive Library Journal of Neurochemistry, 2007, 101, 1085–1098 doi:10.1111/j.1471-4159.2006.04418.x Temporal change in gene expression in the rat dentate gyrus following passive avoidance learning Niamh C. O’Sullivan,* Paul A. McGettigan,* Graham K. Sheridan,* Mark Pickering,* Lisa Conboy,* John J. O’Connor,* Paul N. Moynagh,* Desmond G. Higgins, Ciaran M. Regan* and Keith J. Murphy* *Applied Neurotherapeutics Research Group, UCD Schools of Biomolecular and Biomedical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland Applied Neurotherapeutics Research Group, UCD Schools of Medicine and Medical Science, UCD Conway Institute, University College Dublin, Belfield, Dublin, Ireland Abstract identified the likely transcription factors controlling gene A learning event initiates a cascade of altered gene expression in each post-training period. The role of NFjB, expression leading to synaptic remodelling within the hippo- implicated in the early post-training period was subsequently campal dentate gyrus, a structure vital to memory formation. confirmed with activation and nuclear translocation seen in To illuminate this transcriptional program of synaptic plasticity dentate granule neurons following training. mRNA changes we used microarrays to quantify mRNA from the rat dentate for four genes, LRP3 (0 h), alpha actin (3 h), SNAP25 and gyrus at increasing times following passive avoidance NSF (6–12 h), were validated at message and/or protein learning. Approximately, 500 known genes were transcrip- level and shown to be learning specific. Thus, the memory- tionally regulated across the 24 h post-training period.
    [Show full text]
  • The Master Regulator Gene PRDM2 Controls C2C12 Myoblasts
    Open Access Insights in Biology and Medicine Research Article The master regulator gene PRDM2 controls C2C12 myoblasts proliferation ISSN 2639-6769 and Differentiation switch and PRDM4 and PRDM10 expression Di Zazzo Erika1#, Bartollino Silvia1*# and Moncharmont Bruno1 1Department of Medicine and Health Sciences “V. Tiberio”, University of Molise, Italy #These authors contributed equally to this work *Address for Correspondence: Silvia Bartollino, Abstract Department of Medicine and Health Sciences, “V. Tiberio”, University of Molise Via F. De Sanctis, The Positive Regulatory Domain (PRDM) protein family gene is involved in a spectrum variety of biological 86100 Campobasso, Italy, Tel.: +39 0874404886, processes, including proliferation, differentiation and apoptosis: its member seem to be transcriptional E-mail: [email protected] regulators highly cell type and tissue peculiar, towards histones modifi cations or recruitment of specifi c Submitted: 11 August 2017 interaction patters to modify the expression of target genes. In this study we analyzed the expression profi le of Approved: 20 September 2017 different member of PRDM gene family focusing our attention on the role of PRDM2, PRDM4 and PRDM10 genes Published: 25 September 2017 in mouse C2C12 cell line, during the differentiation of myoblasts into myotubes and speculate about the role of the protein Retinoblastoma protein-interacting zinc fi nger protein 1-RIZ1, coded by PRDM2 gene, as a regulator Copyright: 2017 Di Zazzo E, et al. This is an open access article distributed under the of the proliferation/differentiation switch. Creative Commons Attribution License, which permits unrestricted use, distribution, and Results showed a reduction of PRDM2, PRDM4 and PRDM10 expression level during the commitment of the reproduction in any medium, provided the differentiation of myoblasts into myotubes.
    [Show full text]
  • Myogenin Is a Specific Marker for Rhabdomyosarcoma: an Immunohistochemical Study in Paraffin-Embedded Tissues S
    Myogenin is a Specific Marker for Rhabdomyosarcoma: An Immunohistochemical Study in Paraffin-Embedded Tissues S. Kumar, M.D., E. Perlman, M.D., C.A. Harris, B.Sc., M. Raffeld, M.D., M. Tsokos, M.D. Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda Maryland (SK, CAH, MR, MT), and Johns Hopkins Hospital, Baltimore, Maryland (EP) specific marker for rhabdomyoblastic differentia- Myogenin belongs to a group of myogenic regula- tion. It gives consistent and easily interpretable re- tory proteins whose expression determines com- sults in routinely fixed tissues. mitment and differentiation of primitive mesenchy- mal cells into skeletal muscle. The expression of KEY WORDS: Myogenin, Rhabdomyosarcoma, myogenin has been demonstrated to be extremely Paraffin-embedded tissue, Immunohistochemistry. specific for rhabdomyoblastic differentiation, which Mod Pathol 2000;13(9):988–993 makes it a useful marker in the differential diagno- sis of rhabdomyosarcomas (RMS) from other malig- The differential diagnosis of rhabdomyosarcomas nant small round cell tumors of childhood. Com- (RMS) from other poorly differentiated pediatric mercially available antibodies capable of detecting round cell tumors, including the Ewing’s sarcoma myogenin in routinely processed formalin-fixed family of tumors (ESFT), neuroblastomas, and hema- paraffin-embedded (FFPE) tissue are now available. topoietic neoplasms can be difficult on histologic In this study, we evaluated myogenin expression grounds alone, although the use of an antibody panel using the monoclonal myf-4 antibody (Novocastra including mic-2, desmin, and hematopoietic lineage- Labs) on FFPE in a large number of pediatric tu- specific antibodies now allows an accurate diagnosis mors in order to define the clinical utility of this in the majority of cases.
    [Show full text]
  • In Vitro Effects of Biologically Active Vitamin D on Myogenesis: a Systematic Review
    SYSTEMATIC REVIEW published: 09 September 2021 doi: 10.3389/fphys.2021.736708 In vitro Effects of Biologically Active Vitamin D on Myogenesis: A Systematic Review Kathryn H. Alliband, Sofia V. Kozhevnikova, Tim Parr, Preeti H. Jethwa* and John M. Brameld Division of Food Nutrition and Dietetics, School of Biosciences, University of Nottingham Sutton Bonington Campus, Loughborough, United Kingdom Vitamin D (VD) deficiency is associated with muscle weakness. A reduction in the incidence of falls in the elderly following VD supplementation and identification of the VD receptor within muscle cells suggests a direct effect of VD on muscle, but little is known about the underlying mechanisms. Here we systematically searched the literature to identify effects of active VD [1,25(OH)2D3] on skeletal muscle myogenesis in vitro, with no restriction on year of publication. Eligibility was assessed by strict inclusion/exclusion criteria and agreed by two independent investigators. Twelve relevant pa-pers were identified using four different cell types (C2C12, primary mouse satellite cells, primary Edited by: chick myoblasts, and primary human myoblasts) and a range of myogenic markers Fátima Regina Mena Barreto Silva, Federal University of Santa (myoD, myogenin, creatine kinase, myosin heavy chain, and myotube size). A clear Catarina, Brazil inhibitory effect of 1,25(OH)2D3 on proliferation was reported, while the effects on Reviewed by: the different stages of differentiation were less consistent probably due to variation Tiziana Pietrangelo, University of Studies G. d’Annunzio in cell type, time points and doses of 1,25(OH)2D3 used. However, myotube size Chieti and Pescara, Italy was consistently increased by 1,25(OH)2D3.
    [Show full text]
  • Transcriptional Control by the Smads
    Downloaded from http://cshperspectives.cshlp.org/ on October 2, 2021 - Published by Cold Spring Harbor Laboratory Press Transcriptional Control by the SMADs Caroline S. Hill The Francis Crick Institute, Lincoln’s Inn Fields Laboratory, London WC2A 3LY, United Kingdom Correspondence: [email protected] The transforming growth factor-b (TGF-b) family of ligands elicit their biological effects by initiating new programs of gene expression. The best understood signal transducers for these ligands are the SMADs, which essentially act as transcription factors that are activated in the cytoplasm and then accumulate in the nucleus in response to ligand induction where they bind to enhancer/promoter sequences in the regulatory regions of target genes to either activate or repress transcription. This review focuses on the mechanisms whereby the SMADs achieve this and the functional implications. The SMAD complexes have weak affinity for DNA and limited specificity and, thus, they cooperate with other site-specific transcription factors that act either to actively recruit the SMAD complexes or to stabilize their DNA binding. In some situations, these cooperating transcription factors function to integrate the signals from TGF-b family ligands with environmental cues or with information about cell lineage. Activated SMAD complexes regulate transcription via remodeling of the chromatin template. Consistent with this, they recruit a variety of coactivators and corepres- sors to the chromatin, which either directly or indirectly modify histones and/or modulate chromatin structure. he transforming growth factor-b (TGF-b) Although the SMADs are not the only signal Tfamily of ligands, which include the TGF- transducers downstream of the receptors, they bs, the activins, NODAL, bone morphogenetic will be the only transducers discussed here, as proteins (BMPs), and growth and differentia- they are the subject of this review.
    [Show full text]
  • Screening Identifies Small Molecules That Enhance the Maturation Of
    RESEARCH ARTICLE Screening identifies small molecules that enhance the maturation of human pluripotent stem cell-derived myotubes Sridhar Selvaraj1†, Ricardo Mondragon-Gonzalez1,2†, Bin Xu3, Alessandro Magli1,4, Hyunkee Kim1, Jeanne Laine´ 5, James Kiley1, Holly Mckee1, Fabrizio Rinaldi6, Joy Aho6, Nacira Tabti5, Wei Shen1,3,4, Rita CR Perlingeiro1,4* 1Lillehei Heart Institute, Department of Medicine, University of Minnesota, Minneapolis, United States; 2Departamento de Gene´tica y Biologı´a Molecular, Centro de Investigacio´n y de Estudios Avanzados del IPN (CINVESTAV-IPN), Ciudad de Me´xico, Mexico; 3Department of Biomedical Engineering, University of Minnesota, Minneapolis, United States; 4Stem Cell Institute, University of Minnesota, Minneapolis, United States; 5De´partement de Physiologie, Sorbonne Universite´s, Faculte´ de Me´decine site Pitie´-Salpeˆtrie`re, Paris, France; 6Stem Cell Department, Bio-Techne, Minneapolis, United States Abstract Targeted differentiation of pluripotent stem (PS) cells into myotubes enables in vitro disease modeling of skeletal muscle diseases. Although various protocols achieve myogenic differentiation in vitro, resulting myotubes typically display an embryonic identity. This is a major hurdle for accurately recapitulating disease phenotypes in vitro, as disease commonly manifests at later stages of development. To address this problem, we identified four factors from a small molecule screen whose combinatorial treatment resulted in myotubes with enhanced maturation, as shown by the expression profile of myosin heavy chain isoforms, as well as the upregulation of genes related with muscle contractile function. These molecular changes were confirmed by global chromatin accessibility and transcriptome studies. Importantly, we also observed this maturation in *For correspondence: three-dimensional muscle constructs, which displayed improved in vitro contractile force generation [email protected] in response to electrical stimulus.
    [Show full text]
  • The DNA Binding Activity of TAL-1 Is Not Required to Induce Leukemia/ Lymphoma in Mice
    Oncogene (2001) 20, 3897 ± 3905 ã 2001 Nature Publishing Group All rights reserved 0950 ± 9232/01 $15.00 www.nature.com/onc The DNA binding activity of TAL-1 is not required to induce leukemia/ lymphoma in mice Jennifer O'Neil1, Marilisa Billa1, Sarah Oikemus1 and Michelle Kelliher*,1 1University of Massachusetts Medical School, Department of Molecular Genetics and Microbiology and the Cancer Center, 373 Plantation Street, Worcester, Massachusetts, MA 01605, USA Activation of the basic helix ± loop ± helix (bHLH) gene (Kelliher et al., 1996; Condorelli et al., 1996), further TAL-1 (or SCL) is the most frequent gain-of-function demonstrating the oncogenicity of tal-1. Yet, the mutation in pediatric T cell acute lymphoblastic mechanism(s) of tal-1-induced leukemogenesis remains leukemia (T-ALL). Similarly, mis-expression of tal-1 in unclear. the thymus of transgenic mice results in the development In human leukemic Jurkat cells, tal-1 does not of clonal T cell lymphoblastic leukemia. To determine homodimerize, but forms stable heterodimers with the the mechanism(s) of tal-1-induced leukemogenesis, we ubiquitously expressed bHLH E2A proteins, E12 and created transgenic mice expressing a DNA binding E47 (Hsu et al., 1994b). Members of the E2A family mutant of tal-1. Surprisingly, these mice develop disease, include E2-2, HEB and the products of the E2A gene demonstrating that the DNA binding properties of tal-1 E47 and E12 (Murre et al., 1989; Henthorn et al., 1990; are not required to induce leukemia/lymphoma in mice. Hu et al., 1992). Tal-1/E2A heterodimers preferentially However, wild type tal-1 and the DNA binding mutant recognize the E-box consensus sequence CAGATG both form stable complexes with E2A proteins.
    [Show full text]
  • Vitamin D Inhibits Myogenic Cell Fusion and Expression of Fusogenic Genes
    nutrients Article Vitamin D Inhibits Myogenic Cell Fusion and Expression of Fusogenic Genes Tohru Hosoyama 1,*, Hiroki Iida 1,2, Minako Kawai-Takaishi 1 and Ken Watanabe 3 1 Department of Regenerative Medicine, National Center for Geriatrics and Gerontology, Obu, Aichi 474-8511, Japan; [email protected] (H.I.); [email protected] (M.K.-T.) 2 Department of Orthopaedic Surgery, Nagoya University Graduate School of Medicine, Nagoya, Aichi 466-8560, Japan 3 Department of Bone and Joint Disease, National Center for Geriatrics and Gerontology, Obu, Aichi 474-8511, Japan; [email protected] * Correspondence: [email protected]; Tel.: +81-562-46-2311 Received: 16 June 2020; Accepted: 18 July 2020; Published: 23 July 2020 Abstract: Vitamin D, a fat-soluble vitamin, is an important nutrient for tissue homeostasis and is recently gaining attention for its role in sarcopenia. Although several studies have focused on the role of vitamin D in muscle homeostasis, the molecular mechanism underlying its action on skeletal muscle remains unclear. This study investigated the role of vitamin D in myogenesis and muscle fiber maintenance in an immortalized mouse myogenic cell line. A high concentration of active vitamin D, 1α,25(OH)2D3, decreased the expression of myogenic regulatory factors (MRFs), myf5 and myogenin in proliferating myoblasts. In addition, high concentration of vitamin D reduced myoblast-to-myoblast and myoblast-to-myotube fusion through the inhibition of Tmem8c (myomaker) and Gm7325 (myomerger), which encode muscle-specific fusion-related micropeptides. A similar inhibitory effect of vitamin D was also observed in immortalized human myogenic cells. A high concentration of vitamin D also induced hypertrophy of multinucleated myotubes by stimulating protein anabolism.
    [Show full text]
  • The Regulation of Myogenin Gene Expression Duringthe Embryonic Development of Tile Mouse
    Downloaded from genesdev.cshlp.org on September 27, 2021 - Published by Cold Spring Harbor Laboratory Press The regulation of myogenin gene expression duringthe embryonic development of tile mouse Siu-Pok Yee and Peter w.J. Rigby Laboratory of Eukaryotic Molecular Genetics, Medical Research Council, National Institute for Medical Research, The Ridgeway, Mill Hill, London, NW7 1AA UK The myogenic program can be activated in cultured cells by each of four basic-helix-loop-helix (bHLH) transcription factors, the expression of which is strictly controlled, both temporally and spatially, during embryonic development. To begin to understand the mechanisms by which these regulators ~re regulated themselves, we have used transgenic animals to define the minimal sequences required for the complete recapitulation of the temporal and spatial expression pattern of the myogenin gene during embryogenesis. We show that this can be achieved with only 133 bp of 5'-flanking DNA and identify two essential motifs, which are consensus binding sites for the bHLH proteins and for the proteins of the RSRF family. We show further that these sequences, when juxtaposed to a heterologous promoter, are capable of imposing the myogenin expression pattern. We conclude that the proper regulation of myogenin requires a bHLH protein, most probably Myf-5, the only myogenic bHLH factor known to be present in the embryo at the time that myogenin is activated, and an RSRF-Iike binding activity. Furthermore, the expression pattern of a mutant myogenin promoter lacking the RSRF site reveals the existence of at least two populations of cells within the myotomes and of novel rostrocaudal gradients of expression.
    [Show full text]